Machine-Learning-Enabled Virtual Screening for Inhibitors of Lysine-Specific Histone Demethylase 1

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2021 Dec 24

PMID 34946572

Citations 4

Authors

Jiajun Zhou

Shiying Wu

Boon Giin Lee

Tianwei Chen

Ziqi He

Yukun Lei

Bencan Tang

Jonathan D Hirst

Affiliations

Soon will be listed here.

Abstract

A machine learning approach has been applied to virtual screening for lysine specific demethylase 1 (LSD1) inhibitors. LSD1 is an important anti-cancer target. Machine learning models to predict activity were constructed using Morgan molecular fingerprints. The dataset, consisting of 931 molecules with LSD1 inhibition activity, was obtained from the ChEMBL database. An evaluation of several candidate algorithms on the main dataset revealed that the support vector regressor gave the best model, with a coefficient of determination (R2) of 0.703. Virtual screening, using this model, identified five predicted potent inhibitors from the ZINC database comprising more than 300,000 molecules. The virtual screening recovered a known inhibitor, RN1, as well as four compounds where activity against LSD1 had not previously been suggested. Thus, we performed a machine-learning-enabled virtual screening of LSD1 inhibitors using only the structural information of the molecules.

Citing Articles

Discovery of novel SOS1 inhibitors using machine learning.

Duo L, Chen Y, Liu Q, Ma Z, Farjudian A, Ho W RSC Med Chem. 2024; 15(4):1392-1403.

PMID: 38665844 PMC: 11042245. DOI: 10.1039/d4md00063c.

Lysine-Specific Demethylase 1 Inhibitors: A Comprehensive Review Utilizing Computer-Aided Drug Design Technologies.

Han D, Lu J, Fan B, Lu W, Xue Y, Wang M Molecules. 2024; 29(2).

PMID: 38276629 PMC: 10821146. DOI: 10.3390/molecules29020550.

Deep generative design of porous organic cages a variational autoencoder.

Zhou J, Mroz A, Jelfs K Digit Discov. 2023; 2(6):1925-1936.

PMID: 38054102 PMC: 10695006. DOI: 10.1039/d3dd00154g.

Assisting Multitargeted Ligand Affinity Prediction of Receptor Tyrosine Kinases Associated Nonsmall Cell Lung Cancer Treatment with Multitasking Principal Neighborhood Aggregation.

Nakarin F, Boonpalit K, Kinchagawat J, Wachiraphan P, Rungrotmongkol T, Nutanong S Molecules. 2022; 27(4).

PMID: 35209011 PMC: 8878292. DOI: 10.3390/molecules27041226.

References

Neelamegam R, Ricq E, Malvaez M, Patnaik D, Norton S, Carlin S . Brain-penetrant LSD1 inhibitors can block memory consolidation. ACS Chem Neurosci. 2012; 3(2):120-128. PMC: 3382965. DOI: 10.1021/cn200104y. View

McAllister T, England K, Hopkinson R, Brennan P, Kawamura A, Schofield C . Recent Progress in Histone Demethylase Inhibitors. J Med Chem. 2015; 59(4):1308-29. DOI: 10.1021/acs.jmedchem.5b01758. View

Haywood A, Redshaw J, Hanson-Heine M, Taylor A, Brown A, Mason A . Kernel Methods for Predicting Yields of Chemical Reactions. J Chem Inf Model. 2021; 62(9):2077-2092. DOI: 10.1021/acs.jcim.1c00699. View

Bento A, Gaulton A, Hersey A, Bellis L, Chambers J, Davies M . The ChEMBL bioactivity database: an update. Nucleic Acids Res. 2013; 42(Database issue):D1083-90. PMC: 3965067. DOI: 10.1093/nar/gkt1031. View

Sun X, Zheng Y, Ma C, Yang J, Gao Q, Yan Y . Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening. J Biomol Struct Dyn. 2018; 37(16):4200-4214. DOI: 10.1080/07391102.2018.1538903. View

Gaulton A, Hersey A, Nowotka M, Bento A, Chambers J, Mendez D . The ChEMBL database in 2017. Nucleic Acids Res. 2016; 45(D1):D945-D954. PMC: 5210557. DOI: 10.1093/nar/gkw1074. View

Melville J, Burke E, Hirst J . Machine learning in virtual screening. Comb Chem High Throughput Screen. 2009; 12(4):332-43. DOI: 10.2174/138620709788167980. View

Bergner A, Parel S . Hit expansion approaches using multiple similarity methods and virtualized query structures. J Chem Inf Model. 2013; 53(5):1057-66. DOI: 10.1021/ci400059p. View

Dai X, Liu Y, Xue L, Xiong X, Zhou Y, Zheng Y . Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1. J Med Chem. 2021; 64(5):2466-2488. DOI: 10.1021/acs.jmedchem.0c02176. View

10.

Hayami S, Kelly J, Cho H, Yoshimatsu M, Unoki M, Tsunoda T . Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int J Cancer. 2010; 128(3):574-86. DOI: 10.1002/ijc.25349. View

11.

Maltarollo V, Honorio K, Emery F, Ganesan A, Trossini G . Hologram quantitative structure-activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors. Future Med Chem. 2015; 7(11):1381-94. DOI: 10.4155/fmc.15.68. View

12.

Xu Y, He Z, Liu H, Chen Y, Gao Y, Zhang S . 3D-QSAR, molecular docking, and molecular dynamics simulation study of thieno[3,2-]pyrrole-5-carboxamide derivatives as LSD1 inhibitors. RSC Adv. 2022; 10(12):6927-6943. PMC: 9049714. DOI: 10.1039/c9ra10085g. View

13.

Gale M, Yan Q . High-throughput screening to identify inhibitors of lysine demethylases. Epigenomics. 2015; 7(1):57-65. PMC: 4356004. DOI: 10.2217/epi.14.63. View

14.

Scoumanne A, Chen X . The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and -independent manners. J Biol Chem. 2007; 282(21):15471-5. DOI: 10.1074/jbc.M701023200. View

15.

Wang X, Huang B, Suzuki T, Liu X, Zhan P . Medicinal chemistry insights in the discovery of novel LSD1 inhibitors. Epigenomics. 2015; 7(8):1379-96. DOI: 10.2217/epi.15.86. View

16.

Obermeyer Z, Emanuel E . Predicting the Future - Big Data, Machine Learning, and Clinical Medicine. N Engl J Med. 2016; 375(13):1216-9. PMC: 5070532. DOI: 10.1056/NEJMp1606181. View

17.

Li L, Hoyer S, Pederson R, Sun R, Cubuk E, Riley P . Kohn-Sham Equations as Regularizer: Building Prior Knowledge into Machine-Learned Physics. Phys Rev Lett. 2021; 126(3):036401. DOI: 10.1103/PhysRevLett.126.036401. View

18.

Abdizadeh R, Heidarian E, Hadizadeh F, Abdizadeh T . QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations Studies of Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Anticancer Agents. Anticancer Agents Med Chem. 2020; 21(8):987-1018. DOI: 10.2174/1871520620666200721134010. View

19.

Cramer R, Patterson D, Bunce J . Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc. 2011; 110(18):5959-67. DOI: 10.1021/ja00226a005. View

20.

Willmann D, Lim S, Wetzel S, Metzger E, Jandausch A, Wilk W . Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor. Int J Cancer. 2012; 131(11):2704-9. DOI: 10.1002/ijc.27555. View